439 related articles for article (PubMed ID: 22796503)
1. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
Alt C; Laschinger M; Engelhardt B
Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
[TBL] [Abstract][Full Text] [Related]
4. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
[TBL] [Abstract][Full Text] [Related]
5. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
Huppert J; Closhen D; Croxford A; White R; Kulig P; Pietrowski E; Bechmann I; Becher B; Luhmann HJ; Waisman A; Kuhlmann CR
FASEB J; 2010 Apr; 24(4):1023-34. PubMed ID: 19940258
[TBL] [Abstract][Full Text] [Related]
7. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Guerrini MM; Okamoto K; Komatsu N; Sawa S; Danks L; Penninger JM; Nakashima T; Takayanagi H
Immunity; 2015 Dec; 43(6):1174-85. PubMed ID: 26680207
[TBL] [Abstract][Full Text] [Related]
9. Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
Xu Y; He Z; Li Z; Fang S; Zhang Y; Wan C; Ma Y; Lin P; Liu C; Wang G; Li R; Zhu J; Li Y; Mu L; Zhang Y; Wang J; Kong Q; Li H; Sun B
J Leukoc Biol; 2017 Feb; 101(2):507-517. PubMed ID: 27443879
[TBL] [Abstract][Full Text] [Related]
10. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
[TBL] [Abstract][Full Text] [Related]
11. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
12. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
Kruglov AA; Lampropoulou V; Fillatreau S; Nedospasov SA
J Immunol; 2011 Dec; 187(11):5660-70. PubMed ID: 22058414
[TBL] [Abstract][Full Text] [Related]
14. CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology.
Smorodchenko A; Wuerfel J; Pohl EE; Vogt J; Tysiak E; Glumm R; Hendrix S; Nitsch R; Zipp F; Infante-Duarte C
Eur J Neurosci; 2007 Sep; 26(6):1387-98. PubMed ID: 17880383
[TBL] [Abstract][Full Text] [Related]
15. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
Cohen SJ; Cohen IR; Nussbaum G
J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the choroid plexus in central nervous system inflammation.
Engelhardt B; Wolburg-Buchholz K; Wolburg H
Microsc Res Tech; 2001 Jan; 52(1):112-29. PubMed ID: 11135454
[TBL] [Abstract][Full Text] [Related]
17. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
18. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis.
Wolburg-Buchholz K; Mack AF; Steiner E; Pfeiffer F; Engelhardt B; Wolburg H
Acta Neuropathol; 2009 Aug; 118(2):219-33. PubMed ID: 19533155
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease.
Toft-Hansen H; Füchtbauer L; Owens T
Glia; 2011 Jan; 59(1):166-76. PubMed ID: 21046558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]